310
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Identification and functional characterisation of a novel dopamine beta hydroxylase gene variant associated with attention deficit hyperactivity disorder

, , , , , , , , , & show all
Pages 610-618 | Received 08 Jan 2015, Accepted 30 Mar 2015, Published online: 15 May 2015

References

  • Altshuler D, Brooks L, Chakravarti A, Collins F, Daly M, Donnelly P. 2005. A haplotype map of the human genome. Nature 437:1299–1320.
  • Arnsten AFT. 2011. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry 69:e89–99.
  • Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297.
  • Beltran M, Puig I, Peña C, García JM, Alvarez AB, Peña R, et al. 2008. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22:756–769.
  • Berridge CW, Arnsten AFT. 2013. Psychostimulants and motivated behavior: arousal and cognition. Neurosci Biobehav Rev 37:1976–1984.
  • Bhaduri N, Mukhopadhyay K. 2006. Lack of significant association between -1021C→T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci Lett 402:12–16.
  • Bhaduri N, Sinha S, Chattopadhyay A, Gangopadhyay PK, Singh M, Mukhopadhyay KK. 2005. Analysis of polymorphisms in the dopamine beta hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian Pediatr 42:123–129.
  • Das Bhowmik A, Sarkar K, Ghosh P, Das M, Bhaduri N, Sarkar K, et al. 2013. Significance of dopaminergic gene variants in the male biasness of ADHD. J Atten Disord. Epub ahead of print. Jul 23. doi:10.1177/1087054713494004
  • Bowden CL, Deutsch CK, Swanson JM. 1988. Plasma dopamine-!b-hydroxylase and platelet monoamine oxidase in Attention Deficit Disorder and Conduct Disorder. J Am Acad Child Adolesc Psychiatry 27:171–174.
  • Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11:934–953.
  • Buckland PR. 2006. The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim Biophys Acta 1762:17–28.
  • Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, et al. 2002. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699–711.
  • Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJS, et al. 2013. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes. Eur Neuropsychopharmacol 23:448–457.
  • Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, et al. 2002. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 51:358–364.
  • Cubells JF, Sun X, Li W, Bonsall RW, McGrath JA, Avramopoulos D, et al. 2011. Linkage analysis of in families of patients with schizophrenia. Hum Genet 130:635–643.
  • Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192–196.
  • Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87–98.
  • Gizer I, Ficks C, Waldman I. 2009. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126:51–90.
  • Gong J, Tong Y, Zhang H-M, Wang K, Hu T, Shan G, et al. 2012. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 33:254–263.
  • Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, et al. 2009. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry 14:546–554.
  • Hawi Z, Lowe N, Kirley A, Gruenhage F, Nöthen M, Greenwood T, et al. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8:299–308.
  • Hawi Z, Matthews N, Barry E, Kirley A, Wagner J, Wallace RH, et al. 2013. A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD. Psychopharmacology (Berlin). 225:895–902.
  • Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch K-P, et al. 2009. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 116:121–130.
  • Hinske L, França G, Torres H, Ohara D, Lopes-Ramos C, Heyn J, et al. 2014. miRIAD – Integrating microRNA Inter- And Intragenic Data. Database 2014:bau099.
  • Hoza B. 2007. Peer functioning in children with ADHD. J Pediatr Psychol 32:655–663.
  • IBM SPSS Statistics for Windows (Version 22.0). 2013.
  • Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, et al. 2002. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27:607–619.
  • Kwon HJ, Lim MH. 2013. Association between dopamine Beta-hydroxylase gene polymorphisms and attention-deficit hyperactivity disorder in korean children. Genet Test Mol Biomarkers 17:529–534.
  • Lai EC. 2002. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30:363–364.
  • Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, Maller JB, et al. 2008. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B:1345–1354.
  • Lee SS, Lahey BB, Owens EB, Hinshaw SP. 2008. Few preschool boys and girls with ADHD are well-adjusted during adolescence. J Abnorm Child Psychol 36:373–383.
  • Lewis B, Burge C, Bartel D. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20.
  • Merikangas KR, He J-P, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. 2010. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49:980–989.
  • Mustapic M, Maihofer AX, Mahata M, Chen Y, Baker DG, O’Connor DT, et al. 2014. The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter. Hum Mol Genet 23:6375–6384.
  • Pelechano V, Steinmetz LM. 2013. Gene regulation by antisense transcription. Nat Rev Genet 14:880–893.
  • Pliszka SR. 2005. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1385–1390.
  • Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948.
  • Punia S, Das M, Behari M, Mishra BK, Sahani AK, Govindappa ST, et al. 2010. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians. Pharmacogenet Genomics 20:435–441.
  • Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL. 1982. Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 139:307–311.
  • Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR. 1989. Attention deficit disorder symptoms catecholamines and urine. Psychiatry Res 27:241–251.
  • Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. 2002. Further evidence for the association between attention- deficit/hyperactivity disorder and the dopamine- beta-hydroxylase gene. Am J Med Genet 114:154–158.
  • Scassellati C, Bonvicini C, Faraone S V, Gennarelli M. 2012. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 51:1003–1019.e20.
  • Silverman W, Albano A. 1996. Anxiety Disorders Interview Schedule for Children for DSM-IV: (Child and Parent Versions).San Antonio, TX: Graywind.
  • Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, et al. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet B Neuropsychiatr Genet 119B:77–85.
  • Stallings MC, Corley RP, Hewitt JK, Krauter KS, Lessem JM, Mikulich SK, et al. 2003. A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence. Drug Alcohol Depend 70:295–307.
  • Surgucheva I, Gunewardena S, Rao HS, Surguchov A. 2013. Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs. PLoS One 8:e73786.
  • Tang Y, Buxbaum SG, Waldman I, Anderson GM, Zabetian CP, Köhnke MD, et al. 2006. A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide pol. Biol Psychiatry 60:1034–1038.
  • Thibault C, Lai C, Wilke N, Duong B, Olive MF, Rahman S, et al. 2000. Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol 58:1593–1600.
  • Thomas SA, Marck BT, Palmiter RD, Matsumoto AM. 1998. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70:2468–2476.
  • Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, et al. 2001. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121.
  • Wei C, Thatcher EJ, Olena AF, Cha DJ, Perdigoto AL, Marshall AF, et al. 2013. miR-153 regulates SNAP-25, synaptic transmission, and neuronal development. PLoS One 8:e57080.
  • Weinshilboum R. 1978. Human biochemical genetics of plasma dopamine-beta-hydroxylase and erythrocyte catechol-o- methyltransferase. Hum Genet Suppl 1:101–112.
  • Yang Z, Kaye D. 2009. Mechanistic insights into the link between a polymorphism of the 3′UTR of the SLC7A1 gene and hypertension. Hum Mutat 30:328–333.
  • Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515–522.
  • Zabetian CP, Buxbaum SG, Elston RC, Köhnke MD, Anderson GM, Gelernter J, et al. 2003. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 72:1389–1400.
  • Zhang H-B, Wang Y-F, Li J, Wang B, Yang L. 2005. [Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder]. Zhonghua Er Ke Za Zhi 43:26–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.